Growth Metrics

Insulet (PODD) Payables (2016 - 2026)

Insulet filings provide 16 years of Payables readings, the most recent being $75.0 million for Q4 2025.

  • On a quarterly basis, Payables rose 278.79% to $75.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $75.0 million, a 278.79% increase, with the full-year FY2025 number at $75.0 million, up 278.79% from a year prior.
  • Payables hit $75.0 million in Q4 2025 for Insulet, up from $48.2 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $107.5 million in Q2 2023 to a low of $19.2 million in Q4 2023.
  • Median Payables over the past 5 years was $57.8 million (2021), compared with a mean of $59.3 million.
  • Biggest five-year swings in Payables: crashed 48.2% in 2024 and later skyrocketed 278.79% in 2025.
  • Insulet's Payables stood at $37.7 million in 2021, then decreased by 18.3% to $30.8 million in 2022, then tumbled by 37.66% to $19.2 million in 2023, then grew by 3.12% to $19.8 million in 2024, then skyrocketed by 278.79% to $75.0 million in 2025.
  • The last three reported values for Payables were $75.0 million (Q4 2025), $48.2 million (Q3 2025), and $96.1 million (Q2 2025) per Business Quant data.